Skip to content
Medical Health Aged Care

$30,000 to be won | QV Healthcare Practitioner Student Scholarship Back For 2024

Ego Pharmaceuticals < 1 mins read

Opening on March 4th 2024, the QV Healthcare Practitioner Student Scholarship will award a total of $30,000 in prize money to undergraduate and postgraduate students in Pharmacy, Medicine or Nursing courses in a bid to further the education of the next generation of Australian healthcare practitioners.

Entrants are asked to complete a short essay related to sensitive skin, an area QV understands well having spent decades specialising in skincare for sensitive and problematic skin. Submissions will be judged by a panel of industry experts including Dr. Fabrizio Spada (Scientific Affairs Manager, Ego Pharmaceuticals), Michelle Privitera (President, Eczema Association of Australasia) and Vivienne Speirs (President, Australian Dermatology Nurses' Association).

QV Skincare, part of the Ego Pharmaceuticals portfolio, has a long and close association with healthcare practitioners since the brand was first founded following a request from the dermatology ward of Melbourne’s iconic Queen Victoria Hospital.

Decades on, the QV brand remains family owned, Australian made, and synonymous with quality and innovation. With over 50 QV products sold in more than 20 nations around the world, QV is proud to be Australia’s #1 recommended sensitive skincare brand by healthcare professionals^, a testament to the trust dermatologists, GPs and pharmacists have in the brand.

The QV Healthcare Practitioner Student Scholarship is open from March 4th until June 27th 2024. Interested parties can enter via www.qvskincare.com.au/scholarship.html

^Fifth Quadrant, Sponsored by Ego Pharmaceuticals, OTC Skincare, n = 374, October 2023.


Contact details:

For all media enquiries, please contact Ego Pharmaceuticals:

Courtney Barlow | courtney.barlow@egopharm.com

Media

More from this category

  • Medical Health Aged Care
  • 15/09/2024
  • 07:05
Royal Australian College of GPs

Over 200 new specialist GPs awarded Fellowship in Victoria

Australia’s leading GP training college, the Royal Australian College of GPs (RACGP) welcomed 215 new fellows as specialist general practitioners at a Fellowship ceremony in Victoria on Sunday 15 September. Fellowship of the RACGP (FRACGP) reflects a doctor’s qualification and expertise as a specialist GP, following around 11 years of education, training, rigorous assessment, and experience in primary care. The new GPs recognised at the ceremony at Pullman on the Park East Melbourne included three rural generalists, GPs who complete extra Additional Rural Skills Training in fields needed in rural practice, like anaesthesia and obstetrics . RACGP President Dr Nicole Higgins…

  • Contains:
  • Medical Health Aged Care
  • 13/09/2024
  • 12:40
Zenas BioPharma

Zenas BioPharma Announces Pricing of Upsized Initial Public Offering

WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced the pricing of its upsized initial public offering of 13,235,294 shares of its common stock at an initial public offering price of $17.00 per share. All of the shares are being offered by Zenas. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected to be approximately $225.0 million. Zenas’ common stock is expected to begin trading…

  • Medical Health Aged Care
  • 13/09/2024
  • 12:31
Dementia Australia

New report reinforces dementia as chronic disease of 21st century

Updates to the Dementia in Australia report, released today by the Australian Institute of Health and Welfare (AIHW), reinforce that dementia is an urgent public health issue. Dementia is the second leading cause of death in Australia, the leading cause of death of women, the second leading cause of disease burden overall, and the leading cause of burden for people aged 65 and over. Dementia Australia CEO Professor Tanya Buchanan saidthe report highlights the enormity and impact of dementia in Australia as the chronic disease of the 21st century. “Despite the growing number of Australians diagnosed with dementia – there…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.